110 related articles for article (PubMed ID: 38517251)
1. Targeting human inosine 5' monophosphate dehydrogenase type 2 for anti-dengue lead identification - a computational approach.
Kesavan LR; Kamalan BC; Sivanandan S
J Biomol Struct Dyn; 2024 Mar; ():1-15. PubMed ID: 38517251
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
3. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics.
Tanbin S; Ahmad Fuad FA; Abdul Hamid AA
BioTech (Basel); 2020 Dec; 10(1):. PubMed ID: 35822774
[TBL] [Abstract][Full Text] [Related]
4. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
5. Investigating the effects of four medicinal plants against dengue virus through QSAR modeling and molecular dynamics studies.
Alotaibi F; Aba Alkhayl FF; Foudah AI; Azhar Kamal M; Moglad EH; Khan S; Rehman ZU; Warsi MK; Jawaid T; Alam A
J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38197579
[TBL] [Abstract][Full Text] [Related]
6. Anti-dengue infectivity evaluation of bioflavonoid from
Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
[TBL] [Abstract][Full Text] [Related]
7. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL
Jha RK; Khan RJ; Parthiban A; Singh E; Jain M; Amera GM; Singh RP; Ramachandran P; Ramachandran R; Sachithanandam V; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2022; 40(24):13392-13411. PubMed ID: 34644249
[TBL] [Abstract][Full Text] [Related]
8. Selected phytochemicals of
Huq AKMM; Roney M; Issahaku AR; Sapari S; Ilyana Abdul Razak F; Soliman MES; Mohd Aluwi MFF; Tajuddin SN
J Biomol Struct Dyn; 2023 Sep; ():1-12. PubMed ID: 37676311
[TBL] [Abstract][Full Text] [Related]
9. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
10. Assessing the inhibitory potential of anti-dengue compounds against Japanese encephalitis virus RNA dependent RNA polymerase: an in silico study.
Bajrai LH; Alandijany TA; Alsaady I; El-Daly MM; Tolah AM; Khateb AM; Dubey A; Dwivedi VD; Azhar EI
J Biomol Struct Dyn; 2023 Oct; ():1-17. PubMed ID: 37811742
[TBL] [Abstract][Full Text] [Related]
11. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
12. Computational approaches for innovative anti-viral drug discovery using
Zaib S; Akram F; Waris W; Liaqat ST; Zaib Z; Khan I; Dera AA; Pashameah RA; Alzahrani E; Farouk AE
J Biomol Struct Dyn; 2023; 41(18):8738-8750. PubMed ID: 36300501
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
Gangopadhyay A; Saha A
J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals.
Mufti IU; Sufyan M; Shahid I; Alzahrani AR; Shahzad N; M Alanazi IM; Ibrahim IAA; Rehman S
J Biomol Struct Dyn; 2023 Sep; ():1-12. PubMed ID: 37747078
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore-based virtual screening and
Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening.
Esther Rubavathy SM; Palanisamy K; Priyankha S; Thilagavathi R; Prakash M; Selvam C
J Biomol Struct Dyn; 2023 Nov; 41(19):9492-9502. PubMed ID: 36369945
[TBL] [Abstract][Full Text] [Related]
17. Antiviral actions of natural compounds against dengue virus RNA dependent RNA polymerase: insights from molecular dynamics and Gibbs free energy landscape.
Rabaan AA; Al Kaabi NA; Muzaheed ; Alfaresi M; Garout M; Alotaibi N; Alwashmi ASS; Alsayyah A; Alali NA; Sulaiman T; Alotaibi J; Alissa M
J Biomol Struct Dyn; 2024 Mar; ():1-18. PubMed ID: 38441606
[TBL] [Abstract][Full Text] [Related]
18. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.
Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S
J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552
[TBL] [Abstract][Full Text] [Related]
19. Identification of neo-andrographolide compound targeting NS1 Lys14: an important residue in NS1 activity driving dengue pathogenesis.
Elumalai E; Suresh Kumar M
J Biomol Struct Dyn; 2023 Jul; 41(10):4504-4514. PubMed ID: 35491708
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
